HomeBCX • WSE
add
Bioceltix SA
Previous close
zł 104.40
Day range
zł 102.40 - zł 105.40
Year range
zł 61.60 - zł 129.00
Market cap
509.19M PLN
Avg Volume
7.56K
P/E ratio
-
Dividend yield
-
Primary exchange
WSE
Market news
Financials
Income Statement
Revenue
Net income
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.35M | -13.15% |
Net income | -3.79M | 9.77% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.64M | 11.14% |
Effective tax rate | -0.50% | — |
Balance Sheet
Total assets
Total liabilities
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.57M | 365.54% |
Total assets | 39.31M | 312.46% |
Total liabilities | 4.69M | 43.36% |
Total equity | 34.62M | — |
Shares outstanding | 4.92M | — |
Price to book | 14.85 | — |
Return on assets | -23.53% | — |
Return on capital | -25.62% | — |
Cash Flow
Net change in cash
| (PLN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.79M | 9.77% |
Cash from operations | -557.06K | 74.25% |
Cash from investing | -203.23K | — |
Cash from financing | -300.09K | -100.01% |
Net change in cash | -1.06M | 54.17% |
Free cash flow | 1.05M | 281.30% |
About
Founded
2018
Website
Employees
35
